Neuroone Medical Technologies (NMTC) Total Non-Current Liabilities (2016 - 2026)

Neuroone Medical Technologies (NMTC) has reported Total Non-Current Liabilities for 9 consecutive years, with $2.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Non-Current Liabilities rose 32.08% year-over-year to $2.1 million; the trailing twelve-month figure through Jun 2026 stood at $2.1 million (up 32.08% YoY), and the FY2025 full-year result was $2.4 million, up 1.6% from the prior year.
• Total Non-Current Liabilities rose to $2.1 million in Q2 2026 per NMTC's latest filing, from $1.8 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $2.4 million in Q3 2025 and bottomed at $1.4 million in Q4 2025.
• Historically, Total Non-Current Liabilities has averaged $1.9 million across 3 years, with a median of $1.9 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Total Non-Current Liabilities decreased 24.3% in 2025, then surged 32.08% in 2026.
• Over 3 years, Total Non-Current Liabilities stood at $1.8 million in 2024, then fell by 24.3% to $1.4 million in 2025, then soared by 54.49% to $2.1 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $2.1 million, $1.8 million, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.